Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cucchetti

Showing results (251-260 of 301) with videos related to

Pageof 31
Sort By:
Journal of Hepatology|March 24, 2020
Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplantAlessandro Cucchetti, Matteo Serenari, Carlo Sposito, et al.
Journal of Clinical Medicine|February 4, 2021
External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo StudyFrancesco Giuseppe Foschi, Fabio Conti, Marco Domenicali, et al.
Chirurgia Italiana|April 9, 2008
[Minimally invasive adrenalectomy: transperitoneal vs. retroperitoneal approach]Giovanni Ramacciato, Giuseppe Nigri, Vincenzo Di Santo, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 25, 2012
http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantationAlfonso W Avolio, Salvatore Agnes, Umberto Cillo, et al.
Surgery|April 6, 2016
Defining when to offer operative treatment for intrahepatic cholangiocarcinoma: A regret-based decision curves analysisFabio Bagante, Gaya Spolverato, Alessandro Cucchetti, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 10, 2016
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis DatabaseAndrea Ruzzenente, Fabio Bagante, Francesca Bertuzzo, et al.
Journal of Cancer Research and Clinical Oncology|March 21, 2021
Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysisAndrea Casadei-Gardini, Lorenza Rimassa, Margherita Rimini, et al.
ESMO Open|June 25, 2019
Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectableElena Ongaro, Chiara Cremolini, Daniele Rossini, et al.
Cardiovascular and Interventional Radiology|June 9, 2026
Transarterial Embolization Alone Versus Drug-Eluting Microspheres Chemoembolization for Hepatocellular Carcinoma (RAD-18-TAcE): A Multicenter Randomized Clinical TrialCristina Mosconi, Makoto Taninokuchi Tomassoni, Sara Zanella, et al.
Journal of Hepatology|December 3, 2019
The chances of hepatic resection curing hepatocellular carcinomaAlessandro Cucchetti, Jianhong Zhong, Sarah Berhane, et al.
Pageof 31

Showing results (251-260 of 301) with videos related to

Sort By:
Pageof 31
Journal of Hepatology|March 24, 2020
Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplantAlessandro Cucchetti, Matteo Serenari, Carlo Sposito, et al.
Journal of Clinical Medicine|February 4, 2021
External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo StudyFrancesco Giuseppe Foschi, Fabio Conti, Marco Domenicali, et al.
Chirurgia Italiana|April 9, 2008
[Minimally invasive adrenalectomy: transperitoneal vs. retroperitoneal approach]Giovanni Ramacciato, Giuseppe Nigri, Vincenzo Di Santo, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 25, 2012
http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantationAlfonso W Avolio, Salvatore Agnes, Umberto Cillo, et al.
Surgery|April 6, 2016
Defining when to offer operative treatment for intrahepatic cholangiocarcinoma: A regret-based decision curves analysisFabio Bagante, Gaya Spolverato, Alessandro Cucchetti, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 10, 2016
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis DatabaseAndrea Ruzzenente, Fabio Bagante, Francesca Bertuzzo, et al.
Journal of Cancer Research and Clinical Oncology|March 21, 2021
Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysisAndrea Casadei-Gardini, Lorenza Rimassa, Margherita Rimini, et al.
ESMO Open|June 25, 2019
Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectableElena Ongaro, Chiara Cremolini, Daniele Rossini, et al.
Cardiovascular and Interventional Radiology|June 9, 2026
Transarterial Embolization Alone Versus Drug-Eluting Microspheres Chemoembolization for Hepatocellular Carcinoma (RAD-18-TAcE): A Multicenter Randomized Clinical TrialCristina Mosconi, Makoto Taninokuchi Tomassoni, Sara Zanella, et al.
Journal of Hepatology|December 3, 2019
The chances of hepatic resection curing hepatocellular carcinomaAlessandro Cucchetti, Jianhong Zhong, Sarah Berhane, et al.
Pageof 31